Shilajit Kundu

About

Shilajit Kundu is a leading urologic oncologist whose research has fundamentally shaped the modern surgical landscape for prostate and bladder cancers. His work critically examines the real-world impact of the robotic surgery revolution, providing essential data on how minimally invasive techniques have altered patient outcomes. In a landmark 2012 study (38 citations), Dr. Kundu analyzed national databases to demonstrate how the rapid rise of minimally invasive prostatectomy (MIP) affected the volume and outcomes of open radical prostatectomy, offering a crucial perspective on surgical trends. He has also made significant contributions to bladder cancer care, notably through a 2016 national comparison (29 citations) of oncologic quality indicators between open and robotic-assisted radical cystectomy. Additionally, his investigation into venous thromboembolism after nephrectomy (31 citations) provided vital insights into the incidence and timing of this serious complication. Dr. Kundu’s work is distinguished by its reliance on large, multi-institutional datasets, offering high-level evidence that guides surgical decision-making and quality improvement. His research remains essential reading for understanding the evidence behind the adoption of robotic techniques in urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Impact of Increasing Prevalence of Minimally Invasive Prostatectomy on Open Prostatectomy Observed in the National Inpatient Sample and National Surgical Quality Improvement Program

   38 citations · 2012
2. 2
   Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database

   31 citations · 2017
3. 3
   National comparison of oncologic quality indicators between open and robotic-assisted radical cystectomy

   29 citations · 2016

Key Collaborators

Contact & Links